Using X-ray crystallography-based fragment screening, we mapped VatD’s key binding sites and identified small-molecule fragments that can serve as leads.
This builds on our 2020 Seiple collaboration, where we modified streptogramins to overcome resistance.

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546582